Articles

Translation from research to clinical significance - a due-diligence a…

1st August 2014

Translation from research to clinical significance - a due-diligence analysis Darshan Kulkarni PharmD, MS, Esq. and Deepak Nihalani, PhD

Translational research partnerships help turn academic excellence into new treatments for patients – but they require due diligence at every step along the way.The general public perceives research to be... Read more

Omnichannel marketing for pharma

31st July 2014

Omnichannel marketing for pharmaRobert Harrison

There has been a lot of debate recently around pharma and its pursuit of multi-channel or omni-channel marketing. Given widespread recognition that pharma lags behind a number of market sectors... Read more

Encouraging signs in the quest against Alzheimer’s

30th July 2014

Encouraging signs in the quest against Alzheimer’sJan Lundberg, PhD

Collaboration among experts in Alzheimer's research is aiding progress towards the goals of specific diagnostics for various types of dementia, combined with safe and effective medicines.There were glimmers of hope... Read more

Genomics – the gateway to personalised medicine

29th July 2014

Genomics – the gateway to personalised medicineSarah Holme

Since the completion of the human genome project in 2003, a world of possibilities has been opened up for the personalisation of medicine. From determining predisposition to disease through to... Read more

News

First data from novel Parkinson’s vaccine

1st August 2014

First data from novel Parkinson’s vaccineStaff Reporter

Phase I data for AFFiRiS' PD01A suggests it is worth moving into Phase II.A possible breakthrough in the treatment of Parkinson's disease has been announced by Austrian company AFFiRiS –... Read more

Pfizer buys Baxter vaccines for $635m

1st August 2014

Pfizer buys Baxter vaccines for $635mStaff Reporter

US group will acquire two marketed products plus production facilities in Austria.Pfizer is to pay $635 million for Baxter International's vaccines portfolio, including production facilities, in a deal expected to... Read more

Obama goes public on tax inversion loophole

30th July 2014

Obama goes public on tax inversion loophole

President Barack Obama has made a public pledge to close the tax loophole that allows corporations to avoid paying US corporate taxes by taking over companies in other countries.The White... Read more

AstraZeneca and Kyowa Hakko Kirin partner on immuno-oncology

30th July 2014

AstraZeneca and Kyowa Hakko Kirin partner on immuno-oncologyLinda Banks

AstraZeneca(AZ) is to work with Kyowa Hakko Kirin on a phase I/Ib immuno-oncology study that will evaluate two separate combinations of three investigational compounds in multiple solid tumours.The study will... Read more

Audio & Video

View the recorded webinar - The future o…

WEBINAR COVER smaller


The global pharmaceutical market passes a significant milestone in 2014: reaching one trillion US dollars in total value. IMS Health... View more

Rare Disease Day tweetchat

 

To view a full transcript of the discussion from this #hcsmeu tweetchat held on 28th February 2014 please click View more

Is there common ground for engagement be…

Doctors net webinar

 

The growth of online networks for doctors has been accompanied by recognition from the pharmaceutical industry that these digital meeting grounds can be... View more

Executive Perspectives: Jane Griffiths

 

In the latest in our series of interviews with senior executives who are steering the global pharma industry through a period of unparalleled change, pharmaphorum... View more

White Papers

Diabetes in France

Diabetes in FranceJanet Gunner

Analysis of open social media in relation to a particular disease area can provide useful intelligence on how different treatments and pharmaceutical companies are perceived, by both doctors and patients,... View info

Diabetes in Germany

Diabetes in GermanyJanet Gunner

Analysis of open social media in relation to a particular disease area can provide useful intelligence on how different treatments and pharmaceutical companies are perceived, by both doctors and patients,... View info

Connected data and the use of smartphone…

Connected data and the use of smartphone enabled apps in market researchPaul Mannu

Rapid growth in smartphone usage offers healthcare researchers a useful tool to gain better understanding of how patients and healthcare professionals actually behave on a daily basis. Inaccuracies can arise... View info

Diabetes in the UK

Diabetes in the UKJanet Gunner

Analysis of open social media in relation to a particular disease area can provide useful intelligence on how different treatments and pharmaceutical companies are perceived, by both doctors and patients,... View info

Further News & Articles

AstraZeneca to pay up to $2 billion for Almirall respiratory franchise

AstraZeneca has made a bold move to expand its respiratory franchise by buying up drugs and pipeline candidat... Read more

News

Transmission-blocking vaccines 'could hold key to malaria control'

A vaccine that prevents transmission of the malaria parasite from mosquitoes to people could hold the key to eff... Read more

News

High uptake for Novartis’ meningitis B vaccination programme

Novartis' first-in-class meningitis B vaccine Bexsero has seen high uptake for the first regional vaccination pr... Read more

News

Leukaemia drugs move closer to European approval

Two groundbreaking new treatments for chronic lymphocytic leukaemia have been recommended by Europe's CHMP medic... Read more

News

Australian Health Minister's bid to censor CF comments backfires

Australia's Health Minister Peter Dutton may be regretting his decision to remove posts on his Facebook accou... Read more

News

Synthetic biology firm raises $29m

A US company set up to create engineered bacteria that can both detect and treat diseases has raised $29 mill... Read more

News